youtube_live
Pendapatan Q3 2026 • dikeluarkan • EPS tersasar -29.02% • Hasil melebihi +5.62%
Lihat hasilchevron_right
TNXP:NASDAQ
Tonix Pharmaceuticals Holding Corp
USDÂ 3.01
arrow_downward
-7.10%(-0.23) 1H
USDÂ 3.06
arrow_upward
+1.66% (+0.050)bedtimeSelepas waktu pejabat
Ditutup: 13 Nov, 4:00:00 PTG GMT-5 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk TNXP...
Buka
USDÂ 3.25
Tinggi
USDÂ 3.25
Rendah
USDÂ 2.90
Permodalan Pasaran
58.49J
Purata volum
1.12J
Volum
1.94J
tgi 52 mgu
USDÂ 20.56
rdh 52 mgu
USDÂ 2.90
EPS
-USDÂ 12.92
Beta
1.90
Syer tertunggak
19.43J
Bilangan pekerja
142
Buka
USDÂ 3.25
Tinggi
USDÂ 3.25
Rendah
USDÂ 2.90
Permodalan Pasaran
58.49J
Purata volum
1.12J
Volum
1.94J
tgi 52 mgu
USDÂ 20.56
rdh 52 mgu
USDÂ 2.90
EPS
-USDÂ 12.92
Beta
1.90
Syer tertunggak
19.43J
Bilangan pekerja
142
Cerita berita
Daripada sumber web dan rakan kongsi berita
Yahoo Finance
·
2 hari lalu
Tonix Pharmaceuticals (TNXP) Stock Fair Value Falls As Analysts Weigh Tonmya And Funding Risk
Yahoo Finance
·
3 hari lalu
Tonix Pharmaceuticals’ TONMYA Sales Jump 37% as Insurance Coverage Expands
Profil
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
Perihal Tonix Pharmaceuticals Holding Corp
CEOSeth Lederman
Pekerja142
Diasaskan2007
Ibu pejabatBerkeley Heights, New Jersey, Amerika Syarikat
SektorHealth Care
Industri-
Laman webtonixpharma.com